Cognitive Disability, Motor Disorders
Conditions
Brief summary
This study focuses on the mobile robot assist device for tele-interaction: the "COVEALINK 2" robot. This telepresence robot is designed for remote use inside the home. It works with an Internet connection (Wifi or 4G). It consists of a control interface (an application installed on the smartphone or tablet of the hospitalized patient) and a mobile robot placed in the home of the hospitalized patient (composed of a mobile platform, a visualization screen whose tilt is adjustable remotely for better adaptation to the interlocutors and an audio communication system). From the app installed on his smartphone or tablet, the patient hospitalized in the center for a long time (2 months minimum) will be able to start remotely (from the center where he is hospitalized) the robot and have it move within his home to communicate with the people present at the time of use (family, friends, neighbors etc.).
Interventions
DEVICETelepresence robot
From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)
Sponsors
Association APPROCHE
COVEA
LP3C, University of Rennes 2
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≧ 18 years old * Affiliation to a social security scheme or beneficiary of such a scheme * Having signed a free informed consent in writing * Hospitalized in PRM for a foreseeable period of at least 60 days * Living space compatible with the movement of the robot (verified by a home visit by the center's occupational therapist) and equipped with wifi * Cognitive and motor functions compatible with the use of the tablet or phone independently, with learning capabilities to use the robot and the completion of questionnaires and interviews remotely * Medically stable
Exclusion criteria
* Subject being in a period of exclusion from another protocol * Mood and behavior disorders not stabilized * Insufficient command of the French language * Protected adults (guardianship / curatorship) * Pregnant or breastfeeding women * Persons deprived of their liberty * Being unable to issue their consent * Person who has already presented a form of addiction to technologies and / or video games
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the medium-term acceptance of robotic tele-interaction | At 2 months | Measured with hospitalized patients using questionnaires developed by the LP3C (Laboratory of Psychology, Cognition, Behavior, Communication) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the a priori acceptability of robotic tele-interaction | Day 0 | Measured with hospitalized patients using questionnaires developed by the LP3C (Laboratory of Psychology, Cognition, Behavior, Communication). Measure of the a priori acceptability on Day 0. A priori acceptability corresponds to the study of representations of the user upstream of any use of the technology. |
| Evaluation of the short-term acceptance of robotic tele-interaction | At 1 month | Measured with hospitalized patients using questionnaires developed by the LP3C (Laboratory of Psychology, Cognition, Behavior, Communication). Measurement of acceptance at Day 30. The acceptance phase studies the user's judgment and impressions after the user's first interactions with the system |
| Measure the effects of the use of the telepresence device on the patient's perception of his environment and his psycho-thymic state. | Day 0 | This assessment is done using validated measurement scale relating to depression and anxiety: HAD scale (Hospital Anxiety and Depression). The HAD scale is an instrument used to screen for anxiety and depressive disorders. It comprises 14 items graded from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus making it possible to obtain two scores (maximum score for each score = 21 ).To screen for anxiety and depressive symptoms, the following interpretation is used for each of the scores (A and D): - 7 or less: no symptoms - 8 to 10: doubtful symptomatology - 11 and over: definite symptomatology. |
| Evaluation of the a priori acceptability of robotic tele-interaction for users, relatives and members of the multidisciplinary team | Day 0 | Measurement with categories of users around the patient and members of the multidisciplinary team, using questionnaires developed by the LP3C (Laboratory of Psychology, Cognition, Behavior, Communication). Measurement of a priori acceptability on Day 0. A priori acceptability corresponds to the study of representations of the user upstream of any use of the technology. |
| Evaluation of the medium-term acceptance of robotic tele-interaction for users, relatives and members of the multidisciplinary team | At 2 months | Measurement with categories of users around the patient and members of the multidisciplinary team, using questionnaires developed by the LP3C (Laboratory of Psychology, Cognition, Behavior, Communication). Measurement of acceptance at Day 60. The acceptance phase studies the user's judgment and impressions after the user's first interactions with the system. |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORThibaud Honoré, Doctor
CMRRF de Kerpape
Outcome results
None listed